ALB vs IRD · $8.00B cap vs rev $11.0M
Albemarle Corp (ALB) versus Opus Genetics, Inc. (IRD) — a side-by-side from cached financials, not a winner call.
Albemarle Corp (ALB) is a specialty chemicals company listed on US.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
ALB does not have a complete income-statement cache yet.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
ALB currently screens at market cap $8.00B. IRD currently screens at market cap $35.7M.
Not investment advice. Open the ALB and IRD stock pages for the full models.
Not investment advice.